$DUET
DUET Acquisition Corp Stock $duet

$duet Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000149315223028531 Filed on August 14, 2023

Income Statement

Concept	2023 Q2	2022 Q4	2022 Q2
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$50.00K	$190.2K	$0.00
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$1.068M	$280.6K	$530.6K
YoY Change	101.24%
Operating Profit	-$1.068M		-$530.6K
YoY Change	101.24%
Interest Expense	$851.0K	$436.1K	$122.4K
YoY Change	595.18%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$216.8K	$155.5K	-$408.2K
YoY Change	-46.88%
Income Tax	$168.2K	$229.1K
% Of Pretax Income		147.29%
Net Earnings	-$385.0K	-$73.56K	-$408.2K
YoY Change	-5.67%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.05	-$0.01	-$36.26K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept	2023 Q2	2022 Q4	2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$64.40K	$27.07K	$332.6K
YoY Change	-80.64%
Cash & Equivalents	$64.40K	$27.07K	$332.6K
Short-Term Investments		$88.59M
Other Short-Term Assets		$0.00	$15.00K
YoY Change
Inventory
Prepaid Expenses			$15.00K
Receivables
Other Receivables
Total Short-Term Assets	$64.40K	$27.07K	$347.6K
YoY Change	-81.47%	-87.44%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$53.07M	$88.59M	$87.69M
YoY Change	-39.49%
Total Long-Term Assets	$53.07M	$88.59M	$87.69M
YoY Change	-39.49%
TOTAL ASSETS
Total Short-Term Assets	$64.40K	$27.07K	$347.6K
Total Long-Term Assets	$53.07M	$88.59M	$87.69M
Total Assets	$53.13M	$88.62M	$88.04M
YoY Change	-39.65%	41026.81%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$168.7K	$182.5K
YoY Change
Accrued Expenses	$1.066M	$25.00K	$453.8K
YoY Change	134.95%	1541.5%
Deferred Revenue
YoY Change
Short-Term Debt	$1.033M	$100.0K	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.565M	$726.8K	$453.8K
YoY Change	465.24%	278.55%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$2.588M	$2.588M	$2.588M
YoY Change	0.0%
Total Long-Term Liabilities	$2.588M	$2.588M	$2.588M
YoY Change	0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.565M	$726.8K	$453.8K
Total Long-Term Liabilities	$2.588M	$2.588M	$2.588M
Total Liabilities	$5.153M	$3.314M	$3.041M
YoY Change	69.42%	1626.2%
SHAREHOLDERS EQUITY
Retained Earnings	-$3.219M	-$2.239M	-$2.544M
YoY Change	26.54%	146920.03%
Common Stock	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$3.218M	-$2.239M	-$2.543M
YoY Change
Total Liabilities & Shareholders Equity	$53.13M	$88.62M	$88.04M
YoY Change	-39.65%	41026.81%

Cashflow Statement

Concept	2023 Q2	2022 Q4	2022 Q2
OPERATING ACTIVITIES
Net Income	-$385.0K	-$73.56K	-$408.2K
YoY Change	-5.67%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$151.0K	-$50.10K	-$95.00K
YoY Change	58.93%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$35.82M	$0.00	$0.00
YoY Change
Cash From Investing Activities	$35.82M	$0.00	$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-35.81M	50.00K	0.000
YoY Change
NET CHANGE
Cash From Operating Activities	-151.0K	-50.10K	-95.00K
Cash From Investing Activities	35.82M	0.000	0.000
Cash From Financing Activities	-35.81M	50.00K	0.000
Net Change In Cash	-143.5K	-100.0	-95.00K
YoY Change	51.03%
FREE CASH FLOW
Cash From Operating Activities	-$151.0K	-$50.10K	-$95.00K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001890671
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q2	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue		usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue		usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2022Q2	DUET	Franchise Tax Expenses FranchiseTaxExpenses		usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q1	DUET	Adjustments To Additional Paid In Capital Reclassification AdjustmentsToAdditionalPaidInCapitalReclassification		usd
	DUET	Interest Withdraw From Trust Account InterestWithdrawFromTrustAccount		usd
	DUET	Increase Decrease In Accrued Expenses IncreaseDecreaseInAccruedExpenses		usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense		usd
	DUET	Increase Decrease In Franchise Tax Payable IncreaseDecreaseInFranchiseTaxPayable		usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable		usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement		usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
	DUET	Non Cash Deferred Underwriting Fee Payable NonCashDeferredUnderwritingFeePayable		usd
	DUET	Non Cash Initial Classification Of Class A Ordinary Shares Subject To Redemption NonCashInitialClassificationOfClassAOrdinarySharesSubjectToRedemption		usd
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction		usd
CY2022Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations		pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations		pure
CY2022	DUET	Redemption Of Class Common Stock Including Interest RedemptionOfClassCommonStockIncludingInterest		usd
CY2022	DUET	Remeasurement Of Ordinary Shares Subject To Redemption RemeasurementOfOrdinarySharesSubjectToRedemption		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-41237
	dei	Entity Registrant Name EntityRegistrantName	DUET Acquisition Corp.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-2744116
	dei	Entity Address Address Line1 EntityAddressAddressLine1	V03-11-02, Designer Office
	dei	Entity Address Address Line2 EntityAddressAddressLine2	V03, Lingkaran SV
	dei	Entity Address Address Line3 EntityAddressAddressLine3	Sunway Velocity
	dei	Entity Address City Or Town EntityAddressCityOrTown	Kuala Lumpur
	dei	Entity Address Country EntityAddressCountry	MY
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	55100
	dei	City Area Code CityAreaCode	(914)
	dei	Local Phone Number LocalPhoneNumber	316-4805
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	true
CY2023Q2	us-gaap	Cash Cash	64396	usd
CY2022Q4	us-gaap	Cash Cash	27066	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	64396	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	27066	usd
CY2023Q2	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	53066565	usd
CY2022Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	88592161	usd
CY2023Q2	us-gaap	Assets Assets	53130961	usd
CY2022Q4	us-gaap	Assets Assets	88619227	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1066184	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	25000	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	168747	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	182520	usd
CY2023Q2	DUET	Franchise Tax Payable FranchiseTaxPayable	9714	usd
CY2022Q4	DUET	Franchise Tax Payable FranchiseTaxPayable	190207	usd
CY2023Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	287866	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	229101	usd
CY2023Q2	DUET	Working Capital Loan WorkingCapitalLoan	1032500	usd
CY2022Q4	DUET	Working Capital Loan WorkingCapitalLoan	100000	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	2565011	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	726828	usd
CY2023Q2	DUET	Deferred Underwriter Commission DeferredUnderwriterCommission	2587500	usd
CY2022Q4	DUET	Deferred Underwriter Commission DeferredUnderwriterCommission	2587500	usd
CY2023Q2	us-gaap	Liabilities Liabilities	5152511	usd
CY2022Q4	us-gaap	Liabilities Liabilities	3314328	usd
CY2023Q2	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	5044014	shares
CY2022Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	8625000	shares
CY2023Q2	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.15
CY2022Q4	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.15
CY2023Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	51196742	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	87543750	usd
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3218556	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2239115	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-3218292	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-2238851	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	53130961	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	88619227	usd
CY2023Q2	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1017814	usd
CY2022Q2	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	530612	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1452333	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	922954	usd
CY2023Q2	DUET	Franchise Tax Expenses FranchiseTaxExpenses	50000	usd
	DUET	Franchise Tax Expenses FranchiseTaxExpenses	100000	usd
	DUET	Franchise Tax Expenses FranchiseTaxExpenses	1475	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1067814	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-530612	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1552333	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-924429	usd
CY2023Q2	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	850973	usd
CY2022Q2	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	122408	usd
	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	1736977	usd
	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	150460	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-216841	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-408204	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	184644	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-773969	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	168204	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	343765	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-385045	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-408204	usd
	us-gaap	Net Income Loss NetIncomeLoss	-159121	usd
	us-gaap	Net Income Loss NetIncomeLoss	-773969	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-2238851	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	225923	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-2012928	usd
CY2023Q2	DUET	Stock Issued During Period Value Remeasurement Of Class Common Stock Subject To Redemption StockIssuedDuringPeriodValueRemeasurementOfClassCommonStockSubjectToRedemption	-820319	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-385045	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-3218292	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	23477	usd
CY2022Q1	DUET	Stock Issued During Period Value Sale Of Units In Initial Public Offering StockIssuedDuringPeriodValueSaleOfUnitsInInitialPublicOffering	86250000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-87543750	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	3900000	usd
CY2022Q1	DUET	Stock Issued During Period Value Representative Share StockIssuedDuringPeriodValueRepresentativeShare	862500	usd
CY2022Q1	DUET	Adjustments To Additional Paid In Capital Offering And Underwriting Costs AdjustmentsToAdditionalPaidInCapitalOfferingAndUnderwritingCosts	-2674015	usd
CY2022Q1	DUET	Adjustments To Additional Paid In Capital Deferred Underwriting Commission AdjustmentsToAdditionalPaidInCapitalDeferredUnderwritingCommission	-2587500	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-365765	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-2135053	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-2135053	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-408204	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-408204	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-2543257	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-2543257	usd
	us-gaap	Net Income Loss NetIncomeLoss	-159121	usd
	us-gaap	Net Income Loss NetIncomeLoss	-773969	usd
	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	1736977	usd
	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	150460	usd
	DUET	Interest Withdraw From Trust Account InterestWithdrawFromTrustAccount	620245	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-13773	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	452269	usd
	DUET	Increase Decrease In Accrued Expenses IncreaseDecreaseInAccruedExpenses	1041184	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	15000	usd
	DUET	Increase Decrease In Franchise Tax Payable IncreaseDecreaseInFranchiseTaxPayable	180493	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	58765	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-370170	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-487160	usd
	DUET	Proceeds From Cash Withdrawn From Trust Account In Redemption ProceedsFromCashWithdrawnFromTrustAccountInRedemption	-36347008	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	525000	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	87571802	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	35822008	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-87571802	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	932500	usd
	DUET	Proceeds From Redemption Of Common Stock ProceedsFromRedemptionOfCommonStock	36347008	usd
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	84660072	usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	3900000	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	193535	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-35414508	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	88366537	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	37330	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	307575	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	27066	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	25000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	64396	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	332575	usd
	DUET	Non Cash Deferred Underwriting Fee Payable NonCashDeferredUnderwritingFeePayable	2587500	usd
	DUET	Non Cash Initial Classification Of Class A Ordinary Shares Subject To Redemption NonCashInitialClassificationOfClassAOrdinarySharesSubjectToRedemption	87543750	usd
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	3058	usd
	DUET	Remeasurement Of Ordinary Shares Subject To Redemption RemeasurementOfOrdinarySharesSubjectToRedemption	820319	usd
	DUET	Remeasurement Of Ordinary Shares Subject To Redemption RemeasurementOfOrdinarySharesSubjectToRedemption	87543750	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_80C_eus-gaap--NatureOfOperations_zqA4V7X8BsEh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1. <span id="xdx_827_zEk5rbfoROk6">DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DUET Acquisition Corp. (the “Company”) is a blank check company incorporated in the State of Delaware on September 20, 2021. The Company was formed for the purpose of acquiring, engaging in a share exchange, share reconstruction and amalgamation with, purchasing all or substantially all of the assets of, entering into contractual arrangements with, or engaging in any other similar business combination with one or more businesses or entities (“Business Combination”). The Company is not limited to a particular industry or sector for purposes of consummating a Business Combination.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2023, the Company had not commenced any operations. All activity for the period from September 20, 2021 (inception) through June 30, 2023, relates to the Company’s formation and the initial public offering described below. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the Public Offering (as defined below). The Company has selected December 31 as its fiscal year end.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s sponsor is DUET Partners LLC (the “Sponsor”). The registration statement for the Company’s Initial Public Offering was declared effective on January 19, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 24, 2022, the Company consummated its Initial Public Offering of <span id="xdx_901_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220123__20220124__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z0XAUcqeK8G5" title="Number of stock units issued">7,500,000</span> units (the “Units” and, with respect to the Class A common stock included in the Units being offered, the “Public Shares”), at $<span id="xdx_907_eus-gaap--SaleOfStockPricePerShare_iI_c20220124__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zcJBJvPgGE4j" title="Number of units issued, at par value">10.00</span> per Unit, generating gross proceeds of $<span id="xdx_904_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20220123__20220124__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zFzg5nvKLJEd" title="Proceeds from initial public offering">75,000,000</span>, and incurring offering costs of $<span id="xdx_908_eus-gaap--PaymentsOfStockIssuanceCosts_c20220123__20220124__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zudtJjyZAFe4" title="Incurring offering costs">5,161,516</span>, of which $<span id="xdx_901_eus-gaap--DeferredOfferingCosts_iI_c20220124__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zN8fASajnvS9" title="Deferred offering costs">2,250,500</span> was for deferred underwriting commissions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously with the consummation of the closing of the Offering, the Company consummated the private placement of an aggregate of <span id="xdx_908_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220123__20220124__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__dei--LegalEntityAxis__custom--DuetPartnersLLCMember_zZvfYagFTsc7" title="Number of stock units issued">356,250</span> units (the “Private Placement Units”) to DUET Partners LLC, the sponsor of the Company (the “Sponsor”), at a price of $<span id="xdx_903_eus-gaap--SaleOfStockPricePerShare_iI_c20220124__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__dei--LegalEntityAxis__custom--DuetPartnersLLCMember_zHCtn7TYNGB8" title="Number of units issued, at par value">10.00</span> per Private Placement Unit, generating total gross proceeds of $<span id="xdx_90C_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_c20220123__20220124__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__dei--LegalEntityAxis__custom--DuetPartnersLLCMember_zR8899xyY7w3" title="Proceeds from private placement">3,562,500</span> (the “Private Placement”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsequently, on January 24, 2022, the Company consummated the closing of the sale of <span id="xdx_906_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220123__20220124_zFpGQRRb0UH9" title="Number of stock units issued">1,125,000</span> additional units at a price of $<span id="xdx_903_eus-gaap--SaleOfStockPricePerShare_iI_c20220124_zUsiLptq9tcd" title="Number of units issued, at par value">10</span> per unit (the “Units”) upon receiving notice of the underwriters’ election to fully exercise their overallotment option (“Overallotment Units”), generating additional gross proceeds of $<span id="xdx_900_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20220123__20220124_zCCtV9l8WP81" title="Proceeds from sale of units, net of IPO costs">11,250,000</span> and incurred additional offering costs of $<span id="xdx_90F_eus-gaap--PaymentsOfStockIssuanceCosts_c20220123__20220124_zEjnKx1Nxlea" title="Incurring offering costs">506,250</span>, of which $<span id="xdx_90C_eus-gaap--DeferredOfferingCosts_iI_c20220124_z3PD4asLCMge" title="Deferred offering costs">337,500</span> are for deferred underwriting commissions. Each Unit consists of <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_dc_c20220123__20220124__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z5cCwaF9MT3l" title="Number of common stock issued">one</span> share of Class A common stock of the Company, par value $<span id="xdx_906_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20220124__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zuVrBWqh9cYf" title="Common stock, par value">0.0001</span> per share (“Class A Common Stock”), <span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_dc_c20220124__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zELhwMY9k4ze" title="Number of warrant issued">one</span> redeemable warrant of the Company (“Warrant”), with each whole Warrant entitling the holder thereof to purchase <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_dc_c20220123__20220124__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z6NMGfng19t" title="Number of common stock issued">one</span> share of Class A Common Stock for $<span id="xdx_90F_eus-gaap--SharesIssuedPricePerShare_iI_c20220124__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z53MyvycNsuh" title="Shares issued, per share">11.50</span> per share, subject to adjustment, pursuant to the Company’s registration statement on Form S-1 (File No. 333-261494).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously with the exercise of the overallotment, the Company consummated the Private Placement of an additional <span id="xdx_90A_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220123__20220124__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivatePlacementOneMember__dei--LegalEntityAxis__custom--DuetPartnersLLCMember_zAaDXhsQGPo6" title="Number of stock units issued">33,750</span> Private Placement Units to DUET Partners LLC, a Delaware limited liability company (the “Sponsor”), generating gross proceeds of $<span id="xdx_903_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_c20220123__20220124__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivatePlacementOneMember__dei--LegalEntityAxis__custom--DuetPartnersLLCMember_z3QcKKuCt791" title="Proceeds from sale of private placement units">337,500</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A total of $<span id="xdx_90A_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20220123__20220124_zrUCZnveoZ55" title="Proceeds from offering and private placements">87,543,750</span>, comprised of the proceeds from the Offering and the proceeds of private placements that closed on January 20, 2022 and January 24, 2022, net of the underwriting commissions, discounts, and offering expenses, was deposited in a trust account (“Trust Account”) which may be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the consummation of a Business Combination or (ii) the distribution of the Trust Account to the Company’s stockholders, as described below.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transaction costs of the Initial Public Offering with the exercise of the overallotment amounted to $<span id="xdx_90A_eus-gaap--PaymentsOfStockIssuanceCosts_c20220123__20220124__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zC45oSkisbwg" title="Incurring offering costs">5,667,766</span> consisting of $<span id="xdx_90C_eus-gaap--ExpenseRelatedToDistributionOrServicingAndUnderwritingFees_c20220123__20220124__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zBhRW8oqw5u3" title="Cash underwriting fees">1,293,750</span> of cash underwriting fees, $<span id="xdx_906_ecustom--DeferredUnderwritingFees_c20220123__20220124__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zSxi20jHbYDg" title="Deferred underwriting fees">2,587,500</span> of deferred underwriting fees and $<span id="xdx_90E_ecustom--OtherCostsInExerciseOfOverallotment_c20220123__20220124__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z3CUDHGMciLe" title="Other costs">492,766</span> of other costs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following the closing of the Initial Public Offering $<span id="xdx_90A_eus-gaap--AssetsHeldInTrust_iI_c20220124__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zNtixvTWjX99" title="Cash held in trust account">818,211</span> of cash was held outside of the Trust Account available for working capital purposes. As of June 30, 2023, we have available to us $<span id="xdx_90C_eus-gaap--Cash_iI_c20230630_zJKo8domyzNk" title="Cash">64,396</span> of cash on our balance sheet and a working capital deficit of $<span id="xdx_909_ecustom--WorkingCapital_iI_c20230630_zkPqmR7Zpmoc" title="Working capital">2,500,615</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. NASDAQ rules provide that the Business Combination must be with one or more target businesses that together have a fair market value equal to at least <span id="xdx_901_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_uPure_c20230630__us-gaap--BusinessAcquisitionAxis__custom--DuetPartnersLLCMember__srt--RangeAxis__srt--MinimumMember_zzN4Ndph1ATk" title="Business acquistion, ownership interest percentage">80</span>% of the balance in the Trust Account (less any deferred underwriting commissions and taxes payable on interest earned on the Trust Account) at the time of the signing of a definitive agreement to enter a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires <span id="xdx_904_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_uPure_c20230630__us-gaap--BusinessAcquisitionAxis__custom--DuetPartnersLLCMember_zhaVPChn9dGi" title="Business acquistion, ownership interest percentage">50</span>% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to successfully effect a Business Combination.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company will provide its holders of the outstanding Public Shares (the “public stockholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. In connection with a Business Combination, the Company may seek stockholder approval of a Business Combination at a meeting called for such purpose at which stockholders may seek to redeem their shares, regardless of whether they vote for or against a Business Combination. The Company will proceed with a Business Combination only if the Company has net tangible assets of at least $<span id="xdx_909_eus-gaap--IntangibleAssetsNetIncludingGoodwill_iI_c20230630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zmjpLmofq5E2" title="Intangible assets net">5,000,001</span> either immediately prior to or upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the outstanding shares voted are voted in favor of the Business Combination.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company will have until 15 months (subject to a three month extension of time, as set forth in the Company’s registration statement) from the closing of the Public Offering to consummate a Business Combination (the “Combination Period”). If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than five business days thereafter, redeem <span id="xdx_901_eus-gaap--DebtInstrumentRedemptionPricePercentage_pid_dp_uPure_c20230101__20230630_zTyWA4NeZV01" title="Redemption percentage">100</span>% of the outstanding Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned (net of taxes payable and less interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the Company’s board of directors, proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company, subject in each case to its obligations to provide for claims of creditors and the requirements of applicable law. The underwriter has agreed to waive its rights to the deferred underwriting commission held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Public Offering price per Unit of $<span id="xdx_902_ecustom--SharePriceAvailableForDistributionForPublicOfferingPricePerUnit_iI_c20230630_zp59BTwn7WPa" title="Share price available for distribution for public offering price per unit">10.00</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Sponsor has agreed that it will be liable to the Company, if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amounts in the Trust Account to below $<span id="xdx_906_eus-gaap--SharesIssuedPricePerShare_iI_c20230630__us-gaap--SubsidiarySaleOfStockAxis__custom--ProposedPublicOfferingMember_zmHDHH89WTN2" title="Shares issued, price per share">10.15</span> per share (whether or not the underwriters’ over-allotment option is exercised in full), except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of the Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except for the company’s independent registered accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Going Concern, Liquidity and Capital Resources</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2023, the Company had $<span id="xdx_909_eus-gaap--Cash_iI_c20230630_zY8omDnEsth4" title="Cash in operating bank">64,396</span> of cash in its operating bank account.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s liquidity needs prior to the consummation of the Initial Public Offering were satisfied through the payment of $<span id="xdx_902_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20230101__20230630__srt--TitleOfIndividualAxis__custom--SponsorMember_zdAaNnLq1ZQ5" title="Proceeds from sale of units, net of IPO costs">25,000</span> from the Sponsor to cover for certain offering costs on the Company’s behalf in exchange for issuance of Founder Shares (as defined in Note 5), and loan from the Sponsor of $<span id="xdx_908_eus-gaap--OtherReceivables_iI_c20230630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zqR7cAHgqhGb" title="Other receivables">190,478</span> under the Note (as defined in Note 5). Following the IPO of the Company on January 24, 2022 (as described in Note 1), a total of $<span id="xdx_907_eus-gaap--ProceedsFromRepaymentsOfDebt_c20220123__20220124_zPwsARYEnWs1" title="Promissory note repayment">193,535</span> under the promissory note was repaid on January 24, 2022. Subsequent to the consummation of the Initial Public Offering, the Company’s liquidity has been satisfied through the net proceeds from the consummation of the Initial Public Offering and the Private Placement held outside of the Trust Account. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (as defined in Note 5). As of June 30, 2023, there were $<span id="xdx_903_ecustom--WorkingCapitalLoan_iI_c20230630_zTLfb85JGgY8" title="Working capital loan">1,032,500</span> outstanding under any Working Capital Loan.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on the foregoing, management believes that the Company will have sufficient working capital and borrowing capacity to meet its needs through the earlier of the consummation of a Business Combination or one year from this filing. Over this time period, the Company will be using the funds held outside of the Trust Account for paying existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination. The accompanying financial statements have been prepared in conformity with U.S. GAAP, which contemplates the continuation of the Company as a going concern and the realization of assets and the satisfaction of liabilities in the normal course of business. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. Further, we have incurred and expect to continue to incur significant costs in pursuit of our financing and acquisition plans. Management plans to address this uncertainty during the period leading up to the business combination, however this cannot be guaranteed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	1125000	shares
CY2022Q1	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	10
CY2022Q1	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	11250000	usd
CY2022Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	506250	usd
CY2022Q1	us-gaap	Deferred Offering Costs DeferredOfferingCosts	337500	usd
CY2022Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	87543750	usd
CY2023Q2	us-gaap	Cash Cash	64396	usd
CY2023Q2	DUET	Working Capital WorkingCapital	2500615	usd
	us-gaap	Debt Instrument Redemption Price Percentage DebtInstrumentRedemptionPricePercentage	1	pure
CY2023Q2	DUET	Share Price Available For Distribution For Public Offering Price Per Unit SharePriceAvailableForDistributionForPublicOfferingPricePerUnit	10.00
CY2023Q2	us-gaap	Cash Cash	64396	usd
CY2022Q1	us-gaap	Proceeds From Repayments Of Debt ProceedsFromRepaymentsOfDebt	193535	usd
CY2023Q2	DUET	Working Capital Loan WorkingCapitalLoan	1032500	usd
CY2023Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.7757	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	1.8618	pure
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84F_eus-gaap--UseOfEstimates_zkRgwvEb0JY2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_zeW9yHqwACYf">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2023Q2	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022Q2	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	8625000	shares
	DUET	Redemption Of Class Common Stock Including Interest RedemptionOfClassCommonStockIncludingInterest	37167327	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	87543750	usd
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	87543750	usd
	DUET	Redemption Of Class Common Stock Including Interest RedemptionOfClassCommonStockIncludingInterest	37167327	usd
	DUET	Remeasurement Of Ordinary Shares Subject To Redemption RemeasurementOfOrdinarySharesSubjectToRedemption	820319	usd
CY2023Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	51196742	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	87543750	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84C_eus-gaap--ConcentrationRiskCreditRisk_zCqtzL5JpWgi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_ztQKrSbdkuWh">Concentration of Credit Risk</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal depository insurance coverage of $<span id="xdx_903_eus-gaap--CashFDICInsuredAmount_iI_c20230630_zFoulCihh70d" title="Cash, FDIC insured amount">250,000</span>. On June 30, 2023, the Company had not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.4pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2021Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	2156250	shares
CY2021Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	25000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	281250	usd
CY2023Q2	DUET	Lenders Discretion LendersDiscretion	1500000	usd
CY2023Q2	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	10.00
CY2023Q2	DUET	Working Capital Loan WorkingCapitalLoan	1032500	usd
CY2022Q4	DUET	Working Capital Loan WorkingCapitalLoan	100000	usd
CY2023Q2	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	30000	usd
	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	60000	usd
CY2022Q2	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	30000	usd
	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	60000	usd
	DUET	Underwriting Discount Percentage UnderwritingDiscountPercentage	0.015	pure
	DUET	Deferred Underwriting Fee Percentage DeferredUnderwritingFeePercentage	0.030	pure
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares

Files In Submission

Name	View Source	Status
0001493152-23-028531-index-headers.html	Edgar Link	pending
0001493152-23-028531-index.html	Edgar Link	pending
0001493152-23-028531.txt	Edgar Link	pending
0001493152-23-028531-xbrl.zip	Edgar Link	pending
duet-20230630.xsd	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
duet-20230630_lab.xml	Edgar Link	unprocessable
duet-20230630_cal.xml	Edgar Link	unprocessable
duet-20230630_def.xml	Edgar Link	unprocessable
duet-20230630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
form10-q_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DUET
DUET Acquisition Corp Stock $duet

2023 Q2 Form 10-Q Financial Statement

#000149315223028531 Filed on August 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DUET DUET Acquisition Corp Stock $duet

2023 Q2 Form 10-Q Financial Statement

#000149315223028531 Filed on August 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DUET
DUET Acquisition Corp Stock $duet